ATE443695T1 - Doppelester - Google Patents

Doppelester

Info

Publication number
ATE443695T1
ATE443695T1 AT02779748T AT02779748T ATE443695T1 AT E443695 T1 ATE443695 T1 AT E443695T1 AT 02779748 T AT02779748 T AT 02779748T AT 02779748 T AT02779748 T AT 02779748T AT E443695 T1 ATE443695 T1 AT E443695T1
Authority
AT
Austria
Prior art keywords
leaster
double
esters
alkane
therapeutic
Prior art date
Application number
AT02779748T
Other languages
English (en)
Inventor
Jo Klaveness
Original Assignee
Drug Discovery Lab As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drug Discovery Lab As filed Critical Drug Discovery Lab As
Application granted granted Critical
Publication of ATE443695T1 publication Critical patent/ATE443695T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/50—Sebacic acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/44—Adipic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/48—Azelaic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/96—Esters of carbonic or haloformic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Tires In General (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Lubricants (AREA)
AT02779748T 2001-11-22 2002-11-22 Doppelester ATE443695T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0128052.8A GB0128052D0 (en) 2001-11-22 2001-11-22 Compounds
PCT/GB2002/005305 WO2003045893A1 (en) 2001-11-22 2002-11-22 Double esters

Publications (1)

Publication Number Publication Date
ATE443695T1 true ATE443695T1 (de) 2009-10-15

Family

ID=9926289

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02779748T ATE443695T1 (de) 2001-11-22 2002-11-22 Doppelester

Country Status (15)

Country Link
US (1) US7629383B2 (de)
EP (1) EP1448508B1 (de)
JP (1) JP4426298B2 (de)
KR (1) KR20040071138A (de)
CN (1) CN100516018C (de)
AT (1) ATE443695T1 (de)
AU (1) AU2002343086C1 (de)
CA (1) CA2467773C (de)
DE (1) DE60233819D1 (de)
GB (1) GB0128052D0 (de)
HU (1) HUP0402122A2 (de)
MX (1) MXPA04004763A (de)
NO (1) NO20042603L (de)
RU (1) RU2350599C2 (de)
WO (1) WO2003045893A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
DE102006004804A1 (de) * 2006-01-23 2007-07-26 Intendis Gmbh Verwendung von Alkandicarbonsäuren und Retinoiden zur Behandlung entzündlicher Hauterkrankungen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462934A (en) 1983-03-31 1984-07-31 Pfizer Inc. Bis-esters of dicarboxylic acids with amoxicillin and certain hydroxymethylpenicillanate 1,1-dioxides
EP0125781B1 (de) 1983-04-14 1987-08-12 Interox Chemicals Limited Peroxyd-Zusammensetzungen
GB8310080D0 (en) 1983-04-14 1983-05-18 Interox Chemicals Ltd Bleach composition
ATE74359T1 (de) * 1987-01-27 1992-04-15 Pfizer 6-beta(substituierte)-(s)hydroxymethylpenicillans|ure und deren derivate.
LU86918A1 (fr) * 1987-06-12 1989-03-08 Oreal Nouveaux diesters de l'acide azelaique,leur procede de preparation,les compositions topiques les contenant et leur utilisation dans le traitement de l'acne
CA2107106A1 (en) 1991-03-28 1992-09-29 Jo Klaveness Cross-linking agent
LV10396B (en) 1992-03-06 1996-02-20 Nycomed Imaging As Novel contrast agents
GB9504948D0 (en) * 1995-03-10 1995-04-26 Norwegian Radium Hospital Rese Compounds
JP4029440B2 (ja) 1997-07-09 2008-01-09 大日本インキ化学工業株式会社 側鎖型ラジカル重合性化合物及びそれを用いた液晶デバイス

Also Published As

Publication number Publication date
AU2002343086B2 (en) 2008-01-03
CN1589254A (zh) 2005-03-02
KR20040071138A (ko) 2004-08-11
US7629383B2 (en) 2009-12-08
CA2467773A1 (en) 2003-06-05
GB0128052D0 (en) 2002-01-16
AU2002343086C1 (en) 2008-06-26
JP4426298B2 (ja) 2010-03-03
AU2002343086A1 (en) 2003-06-10
RU2004118713A (ru) 2005-03-27
DE60233819D1 (de) 2009-11-05
EP1448508A1 (de) 2004-08-25
CA2467773C (en) 2011-08-16
WO2003045893A1 (en) 2003-06-05
JP2005510556A (ja) 2005-04-21
MXPA04004763A (es) 2004-07-30
US20050203181A1 (en) 2005-09-15
CN100516018C (zh) 2009-07-22
NO20042603L (no) 2004-06-21
HUP0402122A2 (hu) 2005-02-28
RU2350599C2 (ru) 2009-03-27
EP1448508B1 (de) 2009-09-23

Similar Documents

Publication Publication Date Title
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
ATE508735T1 (de) Pulmonale verabreichung von aminoglykosiden
DE60223254D1 (de) Verzögert freisetzende formulierungen von oxymorphon
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
CY1105082T1 (el) Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
WO2002074337A8 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
AR032293A1 (es) Estuche farmaceutico
AU2002216897A1 (en) Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect
BG108516A (en) Pharmaceutical formulation
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
TR200103125T2 (tr) Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
WO2003007876A3 (en) N-fatty acid-amino acid conjugates and therapeutic uses
SE0001916D0 (sv) Novel formulation
ATE443695T1 (de) Doppelester
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
WO2005034929A3 (en) Tissue remodeling and vascularization
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
ATE241640T1 (de) Fusidinsäure-derivate

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties